Algorithm:Utah2

From NAMIC Wiki
Revision as of 17:59, 6 May 2009 by Gcasey (talk | contribs)
Jump to: navigation, search
Home < Algorithm:Utah2

Back to NA-MIC Algorithms

Overview of Utah 2 Algorithms (PI: Guido Gerig)

At Utah, we are interested in a range of algorithms and solutions for the analysis of DTI and the segmentation of healthy brains and brains with lupus lesions from structural MRI.

Utah 2 Projects

Cbg-dtiatlas-tracts.png

Group Analysis of DTI Fiber Tracts

Analysis of populations of diffusion images typically requires time-consuming manual segmentation of structures of interest to obtain correspondance for statistics. This project uses non-rigid registration of DTI images to produce a common coordinate system for hypothesis testing of diffusion properties. More...

New: # Casey B. Goodlett, P. Thomas Fletcher, John H. Gilmore, Guido Gerig. Group Analysis of DTI Fiber Tract Statistics with Application to Neurodevelopment. NeuroImage 45 (1) Supp. 1, 2009. p. S133-S142. pubdb

DTINoiseStatistics.png

Influence of Imaging Noise on DTI Statistics

Clinical acquisition of diffusion weighted images with high signal to noise ratio remains a challenge. The goal of this project is to understand the impact of MR noise on quantiative statistics of diffusion properties such as anisotropy measures, trace, etc. More...

New: Casey Goodlett, P. Thomas Fletcher, Weili Lin, Guido Gerig. Quantification of measurement error in DTI: Theoretical predictions and validation, MICCAI 2007.

UtahAtlasSegmentation.png

Atlas Based Brain Segmentation

Automatic segmentation can be performed reliably using priors from brain atlases and an image generative model. We have developed a tool that provides an automatic segmentation pipeline in a modular framework. More...

LesionSegmentation.png

Lesion Segmentation

Quantification, analysis and display of brain pathology such as white matter lesions as observed in MRI is important for diagnosis, monitoring of disease progression, improved understanding of pathological processes and for developing new therapies. More...